8:15-8:30 |
Welcome and Introductions |
8:30-9:00 |
Overview of the Bioelectronic Medicine Industry James Cavuoto, Editor, Neurotech Reports
BioElectRx Business Report Editor James Cavuoto presents an overview of the bioelectronic medicine industry, including key players, technological roots, and market projections. |
9:00-9:30 |
Keynote Address
Lisa Shafer, Ph.D., Vice President, Product Development, Biogen
A pharmaceutical industry executive and medtech veteran offers their views on the future of bioelectronic medicine. |
9:30-10:15 |
Investment in Bioelectronic Medicine
JoJo Platt, Senior Contributing Editor, Neurotech Reports, Moderator
Jeff Chu, Managing Partner, Features Capital
Jeffrey Scott Cohen, Director of Research, Ladenburg Thalmann & Co.
Mir Imran, Managing Partner, InCube Ventures
In this session, investment professionals active in the life sciences industry will offer their views on the investment climate for bioelectronic medicine. |
10:15-10:45 |
Refreshment Break |
10:45-11:30 |
Entrepreneur Panel I
James Cavuoto, Editor, Neurotech Reports, Moderator
Jay Sanguinetti, Ph.D., CEO and President, Sanmai Technologies
Colin Kealey, M.D., President and CEO, NeuroSigma, Inc.
Daniel Powell, CEO, Spark Biomedical and 5 Liters
Presentations from executives of emerging bioelectronic medicine firms. |
11:30-12:15 |
Regulatory and Reimbursement Issues
James Cavuoto, Editor, Neurotech Reports, Moderator
Carlos Pena, Ph.D., Chief Regulatory Officer, The Jacobs Institute
Tim Majenin Ph.D., Vice President, Neurology Regulatory Affairs, MCRA
Victor Pikov, Ph.D., Contributing Editor, BioElectRx Business Report
In this session, we'll look at recent developments in regulatory and reimbursement activity for biolelectronic medicine systems. |
12:15-1:15 |
Luncheon
|
1:15-1:30 |
Luncheon Speaker
|
1:30-2:15 |
Respiratory Disorders
Victor Pikov, Ph.D., Contributing Editor, BioElectRx Business Report, Moderator
Olivier Taelman, CEO, Nyxoah
John Rondoni, Chief Product and Innovation Officer, Inspire Medical Systems Inc.
Ahmet Tezel, Ph.D., Chief Innovation Officer, LivaNova
The neuromodulation market for treating disorders such as obstructive sleep apnea is one of the most promising segments of the bioelectronic emdicine industry. In this session, we'll look at the competitive outlook and opportunities for innovation. |
2:15-3:00 |
Entrepreneur Panel II
Jeremy Koff, Senior Consulting Editor, Neurotech Reports, Moderator
Frederik Ceyssens, Ph.D., Co-founder and CEO, ReVision Implant
Chad Andresen, Chief Business Officer, LunOSA
Karl Stoklosa, CEO, Precisis GmbH
Presentations from executives of emerging bioelectronic medicine firms. |
3:00-3:30 |
Refreshment Break |
3:30-4:15 |
Entrepreneur Panel III
JoJo Platt, Senior Contributing Editor, Neurotech Reports, Moderator
Charles Nolet, CEO, Synergia Medical
Yi-Kai Lo, Ph.D., Co-Founder and CEO, ANEUVO
Presentations from executives of emerging bioelectronic medicine firms. |
4:15-5:00 |
Bowel and Bladder Neuromodulation: A Fireside Chat with Ray Cohen
Jeremy Koff, Senior Consulting Editor, Neurotech Reports, Moderator
Ray Cohen, Former CEO, Axonics Inc.
The market for neuromodulation therapies that treat disorders such as OAB changed dramatically with Boston Scientific's recent purchase of Axonics. In this session, former Axonics CEO Ray Cohen sits down with Jeremy Koff to discuss the new landscape. |
5:00-6:30 |
Cocktail Reception
|
|
|